Trisomy 3, a sole recurrent cytogenetic abnormality in pediatric polymorphic post-transplant lymphoproliferative disorder (PTLD)


      • Long-term follow up and clinicopathologic review of two pediatric patients following cardiac and intestine/liver allograft.
      • EBV-positive polymorphus post-transplant lymphoproliferative disorder (PTLD) with Trisomy 3.
      • Recurrent trisomy 3 in polymorphus PTLD in two pediatric patients.


      Trisomy 3 has been previously reported in association with T-cell lymphomas and less commonly in different types of non-Hodgkin B-cell lymphomas. Trisomy 3 has also been reported in two cases of pediatric post-transplant lymphoproliferative disorder (PTLD). We present comprehensive clinicopathologic review of two pediatric patients with cardiac and liver/intestinal allografts that developed polymorphic PTLD characterized by trisomy 3. Both patients had Epstein-Barr virus (EBV) viremia and EBV was positive in tissue by EBER in situ hybridization. Using karyotype analysis and fluorescence in situ hybridization, we identified trisomy 3 in both patients. Both patients responded to treatment and are now free of the PTLD. Trisomy 3, an uncommon cytogenetic finding in pediatric polymorphic PTLD, may be a recurrent cytogenetic aberration if confirmed in a larger study of pediatric PTLDs. Further clinical follow up might help stratify significance of trisomy 3 as a prognostic factor.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Cancer Genetics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Webber S.A.
        • Naftel D.C.
        • Fricker F.J.
        • et al.
        Lymphoproliferative disorders after paediatric heart transplantation: a multi-institutional study.
        Lancet Lond Engl. 2006; 367: 233-239
        • Uhlin M.
        • Wikell H.
        • Sundin M.
        • et al.
        Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.
        Haematologica. 2014; 99: 346-352
        • Natkunam Y.
        • Gratzinger D.
        • Chadburn A.
        • et al.
        Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal.
        Blood. 2018; 132: 1871-1878
      1. Swerdlow S.H. Campo E. Harris N.L. Jaffe E.S. Pileri S.A. Stein H. Thiele J. Vardiman J.W. World health organization classification of tumours of haematopoietic and lymphoid tissues. 4 ed. IARC Press, Lyon, France2017: p443-p461
        • Opelz G.
        • Döhler B.
        Lymphomas after solid organ transplantation: a collaborative transplant study report.
        Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2004; 4: 222-230
        • Dharnidharka V.R...
        Comprehensive review of post-organ transplant hematologic cancers.
        Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg. 2018; 18: 537-549
        • Montanari F.
        • O'Connor O.A.
        • Savage D.G.
        • et al.
        Bone marrow involvement in patients with posttransplant lymphoproliferative disorders: incidence and prognostic factors.
        Hum Pathol. 2010; 41: 1150-1158
        • Nijland M.L.
        • Kersten M.J.
        • Pals S.T.
        • Bemelman F.J.
        • ten Berge I.J.M.
        Epstein-barr virus–positive posttransplant lymphoproliferative disease after solid organ transplantation: pathogenesis.
        Clin Manifestations Diagnos Manag Transplant Direct. 2015; 2
        • Poirel H.A.
        • Bernheim A.
        • Schneider A.
        • et al.
        Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
        Transplantation. 2005; 80: 176-184
        • Menter T.
        • Juskevicius D.
        • Alikian M.
        • et al.
        Mutational landscape of B-cell post-transplant lymphoproliferative disorders.
        Br J Haematol. 2017; 178: 48-56
        • Kluin P.M.
        • Schuuring E...
        Molecular cytogenetics of lymphoma. Where do we stand in 2010.
        Histopathology. 2011; 58: 128
        • Azad V.F.
        • Mehrvar A.
        • Mehrvar N.
        Trisomy 3 as an acquired cytogenetic abnormality in primary acute megakaryoblastic leukemia.
        J Cancer Res Ther. 2018; 14: S800-S802
        • Gallego M.S.
        • Bernasconi A.
        • Dávila M.T.
        • et al.
        Trisomy 3 in two paediatric post-transplant lymphomas.
        Br J Haematol. 2002; 117: 558-562
        • Perry A.M.
        • Aoun P.
        • Coulter D.W.
        • Sanger W.G.
        • Grant W.J.
        • Coccia P.F.
        Early onset, EBV(-) PTLD in pediatric liver-small bowel transplantation recipients: a spectrum of plasma cell neoplasms with favorable prognosis.
        Blood. 2013; 121: 1377-1383
        • McGowan-Jordan J.
        • Simons A.
        • Schmid M.
        Karger S. 1 edition. 2016
        • Itoyama T.
        • Chaganti R.S.K.
        • Yamada Y.
        • et al.
        Cytogenetic analysis and clinical significance in adult T-cell leukemia/lymphoma: a study of 50 cases from the human T-cell leukemia virus type-1 endemic area, Nagasaki.
        Blood. 2001; 97: 3612-3620
        • Kanakry J.A.
        • Li H.
        • Gellert L.L.
        • et al.
        Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
        Blood. 2013; 121: 3547-3553
        • Meckiff B.J.
        • Ladell K.
        • McLaren J.E.
        • et al.
        Primary EBV infection induces an acute wave of activated antigen-specific cytotoxic CD4+ T Cells.
        J Immunol. 2019; 203: 1276-1287
        • Zhang X.-.Y.
        • Collins G.P.
        • Soilleux E.
        • Eyre T.A.
        Acute EBV masquerading as peripheral T-cell lymphoma.
        BMJ Case Rep. 2016; : 2016
        • Hussein K.
        • Tiede C.
        • Maecker-Kolhoff B.
        • Kreipe H.
        Posttransplant lymphoproliferative disorder in pediatric patients.
        Pathobiology. 2013; 80: 289-296
        • Djokic M.
        • Le Beau M.M.
        • Swinnen L.J.
        • et al.
        Post-transplant lymphoproliferative disorder subtypes correlate with different recurring chromosomal abnormalities.
        Genes Chromosomes Cancer. 2006; 45: 313-318
        • Morscio J.
        • Dierickx D.
        • Tousseyn T.
        Molecular pathogenesis of B-Cell posttransplant lymphoproliferative disorder: what do we know so far.
        Clin Dev Immunol. 2013; : 2013
        • Salido M.
        • Baró C.
        • Oscier D.
        • et al.
        Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group.
        Blood. 2010; 116: 1479-1488
        • Baliakas P.
        • Puiggros A.
        • Xochelli A.
        • et al.
        Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference.
        Haematologica. 2016; 101: e299-e302
        • Tagawa H.
        • Karube K.
        • Guo Y.
        • et al.
        Trisomy 3 is a specific genomic aberration of t(14;18) negative follicular lymphoma.
        Leukemia. 2007; 21: 2549-2551
        • Lepretre S.
        • Buchonnet G.
        • Stamatoullas A.
        • et al.
        Chromosome abnormalities in peripheral T-cell lymphoma.
        Cancer Genet Cytogenet. 2000; 117: 71-79
        • Zhou Y.
        • Xu Z.
        • Lin W.
        • et al.
        Comprehensive genomic profiling of EBV-positive diffuse large B-cell lymphoma and the expression and clinicopathological correlations of some related genes.
        Front Oncol. 2019; 9
        • Chen J...
        Roles of the PI3K/Akt pathway in Epstein-Barr virus-induced cancers and therapeutic implications.
        World J Virol. 2012; 1: 154-161
        • Delecluse S.
        • Yu J.
        • Bernhardt K.
        • et al.
        Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs.
        PLoS ONE. 2019; 14e0222847
        • Maecker B.
        • Jack T.
        • Zimmermann M.
        • et al.
        CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
        J Clin Oncol. 2007; 25: 4902-4908
        • Koh B.Y.
        • Rosenthal P.
        • Medeiros L.J.
        • et al.
        Posttransplantation lymphoproliferative disorders in pediatric patients undergoing liver transplantation.
        Arch Pathol Lab Med. 2001; 125: 337-343
        • Fasan O.
        • Willmott C.
        • Czepulkowski B.
        • et al.
        Epstein-Barr virus-related post-transplant lymphoproliferative disorder with t(9;14)(p11-12;q32).
        Cancer Genet Cytogenet. 2003; 142: 134-136
        • Epperly R.
        • Ozolek J.
        • Soltys K.
        • Cohen D.
        • Goyal R.
        • Friehling E.
        Treatment of pediatric plasma cell myeloma type post-transplant lymphoproliferative disorder with modern risk-directed therapy.
        Pediatr Blood Cancer. 2018; 65: e27283
        • Proctor Short S.R.
        • Cook S.L.
        • Kim A.S.
        • Lamour J.M.
        • Lowe E.J.
        • Petersen W.C.
        Plasmacytoma-like posttransplant lymphoproliferative disorder in a pediatric heart transplant recipient.
        J Pediatr Hematol Oncol. 2016; 38: e71-e74
      2. Picarsic J., Jaffe R., Mazariegos G., et al. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Cancer.

        • Kusuki S.
        • Hashii Y.
        • Fukushima N.
        • et al.
        Pediatric post-transplant diffuse large B cell lymphoma after cardiac transplantation.
        Int J Hematol. 2009; 89: 209-213
        • Kraus M.D.
        • Crawford D.F.
        • Kaleem Z.
        • Shenoy S.
        • MacArthur C.A.
        • Longtine J.A.
        T gamma/delta hepatosplenic lymphoma in a heart transplant patient after an Epstein-Barr virus positive lymphoproliferative disorder: a case report.
        Cancer. 1998; 82: 983-992
        • Wang L.C.
        • Lu M.Y.
        • Yu J.
        • et al.
        T cell lymphoproliferative disorder following bone marrow transplantation for severe aplastic anemia.
        Bone Marrow Transplant. 2000; 26: 893-897
        • Bierman P.J.
        • Vose J.M.
        • Langnas A.N.
        • et al.
        Hodgkin's disease following solid organ transplantation.
        Ann Oncol. 1996; 7: 265-270
        • M.A. Nalesnik
        • Randhawa P.
        • Demetris A.J.
        • Casavilla A.
        • Fung J.J.
        • Locker J.
        Lymphoma resembling Hodgkin disease after posttransplant lymphoproliferative disorder in a liver transplant recipient.
        Cancer. 1993; 72: 2568-2573